title: Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
abstract: A new approach to the production and delivery of vaccine antigens is the use of engineered amino virus-based vectors. A chimeric peptide containing antigenic determinants from rabies virus glycoprotein (G protein) (amino acids 253-275) and nucleoprotein (N protein) (amino acids 404-418) was PCR-amplified and cloned as a translational fusion product with the alfalfa mosaic virus (AlMV) coat protein (CP). This recombinant CP was expressed in two plant virus-based expression systems. The first one utilized transgenic Nicotiana tabacum cv. Samsun NN plants providing replicative functions in trans for full-length infectious RNA3 of AlMV (NF1-g24). The second one utilized Nicotiana benthamiana and spinach (Spinacia oleracea) plants using autonomously replicating tobacco mosaic virus (TMV) lacking native CP (Av/A4-g24). Recombinant virus containing the chimeric rabies virus epitope was isolated from infected transgenic N. tabacum cv. Samsun NN plants and used for parenteral immunization of mice. Mice immunized with recombinant virus were protected against challenge infection. Based on the previously demonstrated efficacy of this plant virus-based experimental rabies vaccine when orally administered to mice in virus-infected unprocessed raw spinach leaves, we assessed its efficacy in human volunteers. Three of five volunteers who had previously been immunized against rabies virus with a conventional vaccine specifically responded against the peptide antigen after ingesting spinach leaves infected with the recombinant virus. When rabies virus non-immune individuals were fed the same material, 5/9 demonstrated significant antibody responses to either rabies virus or AlMV. Following a single dose of conventional rabies virus vaccine, three of these individuals showed detectable levels of rabies virus-neutralizing antibodies, whereas none of five controls revealed these antibodies. These findings provide clear indication of the potential of the plant virus-based expression systems as supplementary oral booster for rabies vaccinations.
authors.affiliation: Biotechnology Foundation Laboratories at Thomas Jefferson University, 1020 Locust Street, Room 346 JAH, Philadelphia, PA 19107, USA.
authors.forename: V
authors.initials: V
authors.lastname: Yusibov
authors.forename: D C
authors.initials: DC
authors.lastname: Hooper
authors.forename: S V
authors.initials: SV
authors.lastname: Spitsin
authors.forename: N
authors.initials: N
authors.lastname: Fleysh
authors.forename: R B
authors.initials: RB
authors.lastname: Kean
authors.forename: T
authors.initials: T
authors.lastname: Mikheeva
authors.forename: D
authors.initials: D
authors.lastname: Deka
authors.forename: A
authors.initials: A
authors.lastname: Karasev
authors.forename: S
authors.initials: S
authors.lastname: Cox
authors.forename: J
authors.initials: J
authors.lastname: Randall
authors.forename: H
authors.initials: H
authors.lastname: Koprowski
mesh_terms: D000284:Administration, Oral; D017794:Alfalfa mosaic virus / Q000235:genetics; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000276:immunology; D036022:Capsid Proteins / Q000502:physiology; D003673:Defective Viruses / Q000235:genetics; D005502:Food; D006023:Glycoproteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D006801:Humans; D051379:Mice; D008809:Mice, Inbred C3H; D009500:Neutralization Tests; D009698:Nucleoproteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D018515:Plant Leaves; D030821:Plants, Genetically Modified / Q000378:metabolism; D011819:Rabies Vaccines / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D011820:Rabies virus / Q000235:genetics / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D013045:Species Specificity; D018724:Spinacia oleracea / Q000235:genetics / Q000378:metabolism*; D014026:Nicotiana / Q000235:genetics / Q000378:metabolism*; D014027:Tobacco Mosaic Virus / Q000235:genetics; D014611:Vaccination / Q000379:methods; D022223:Vaccines, Subunit / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D014614:Vaccines, Synthetic / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D014764:Viral Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D036022:Capsid Proteins; D006023:Glycoproteins; D009698:Nucleoproteins; D011819:Rabies Vaccines; D011993:Recombinant Fusion Proteins; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; D014764:Viral Proteins; C095691:coat protein, Alfalfa mosaic virus; C472447:rabies virus glycoprotein (253-275); C472448:rabies virus nucleoprotein N (404-418)